Which Enzyme Is Responsible For Transcription

You're staring at a biology exam question. You know it's not DNA polymerase — that's replication. And the textbook mentions three in eukaryotes. " Your mind blanks. "Which enzyme is responsible for transcription?But is it just "RNA polymerase"? And prokaryotes only have one. That said, which one? And what about viruses?

Yeah. It's a deceptively simple question with layers. Small thing, real impact.

What Is Transcription (And Why the Enzyme Matters)

Transcription is the process where a DNA sequence gets copied into RNA. That RNA then goes on to do the work — messenger RNA carries the code to ribosomes, ribosomal RNA builds the ribosome itself, transfer RNA shuttles amino acids. None of it happens without the enzyme that reads the DNA template and stitches ribonucleotides together.

That enzyme is RNA polymerase.

But here's where most students (and honestly, a lot of introductory textbooks) oversimplify: they treat "RNA polymerase" like it's a single, universal machine. It's not. coli* looks and behaves differently from the three main versions in human cells. The version in E. And if you're studying a retrovirus like HIV, the enzyme running the show isn't even a standard RNA polymerase — it's reverse transcriptase, which goes the other direction.

So the real answer depends on context. Let's unpack it.

Why It Matters: More Than a Vocabulary Word

You might wonder why the distinction between RNA Pol I, II, and III matters outside a multiple-choice test.

Because it explains regulation*.

RNA polymerase II transcribes all protein-coding genes — every enzyme, structural protein, signaling molecule, transcription factor. On top of that, hepatocyte? That means the control of Pol II activity is the control of what a cell becomes. Neuron vs. Cancer? This leads to different Pol II targets. Same genome. Often Pol II run amok on oncogenes or stalled on tumor suppressors.

RNA polymerase I churns out ribosomal RNA in the nucleolus. Think about it: that's the factory floor. If Pol I goes haywire, ribosome biogenesis goes haywire — a hallmark of many cancers.

RNA polymerase III makes tRNAs, 5S rRNA, and other small RNAs. Housekeeping on the surface, but its dysregulation shows up in neurodegenerative diseases and viral replication strategies.

And in bacteria? A single RNA polymerase holoenzyme does it all — mRNA, rRNA, tRNA — with sigma factors telling it where to start. That simplicity is why bacteria can divide every 20 minutes. It's also why antibiotics like rifampicin target the bacterial enzyme specifically: they hit the beta subunit of prokaryotic RNA pol and leave eukaryotic polymerases alone.

So when someone asks "which enzyme," the answer isn't trivia. It's a gateway to understanding gene expression, drug targets, and disease mechanisms.

How It Works: The Enzyme(s) in Action

Prokaryotes: One Core, Many Sigmas

In bacteria and archaea, the core RNA polymerase is a five-subunit complex: α₂ββ'ω. That's two alpha, one beta, one beta-prime, one omega. On its own, it can elongate RNA but can't find promoters specifically.

Enter the sigma factor.

Sigma binds the core, forming the holoenzyme. Sigma region 2.On the flip side, 2 reads the -35. Now it recognizes promoter sequences — the -35 and -10 elements (Pribnow box) in E. Think about it: coli*. 4 reads the -10. And region 4. Once positioned, the holoenzyme melts ~14 base pairs of DNA, forms the open complex, and starts synthesizing RNA.

After ~10 nucleotides, sigma often falls off. The core enzyme continues elongation. Termination happens either via rho-dependent (protein factor) or rho-independent (hairpin in the RNA) mechanisms.

E. coli* has seven sigma factors. But σ⁷⁰ (RpoD) handles housekeeping. σ³² (RpoH) kicks in during heat shock. σᴱ handles envelope stress. Practically speaking, each sigma redirects the same* core polymerase to a different gene set. Elegant economy.

Eukaryotes: Three Specialists, One Ancestral Core

Eukaryotes split the workload across three nuclear RNA polymerases. All share a common ancestor with bacterial RNA pol — you can see it in the conserved beta/beta-prime-like subunits — but they've diverged.

RNA Polymerase I: The Ribosome Factory

Located in the nucleolus. In practice, transcribes the large rRNA precursor (45S in humans) that gets processed into 28S, 18S, and 5. 8S rRNA. That's the structural and catalytic core of the ribosome.

Pol I is a 14-subunit monster (~590 kDa). It has a dedicated initiation factor (SL1/TIF-IB in humans, containing TBP and TAFs) and a termination factor (TTF-I). Its promoter has an upstream control element and a core element — no TATA box.

Because rRNA demand scales with growth rate, Pol I activity is a major integration point for nutrient signaling (mTOR pathway, etc.Cancer cells often show hyperactive Pol I — nucleoli get huge. ). That's not decorative; it's diagnostic.

RNA Polymerase II: The Protein-Coding Engine

This is the one most people mean when they say "RNA polymerase.So 12 subunits (~550 kDa). So " It transcribes all mRNA, most snRNAs, snoRNAs, microRNAs, and long non-coding RNAs. The largest subunit, RPB1, has a unique C-terminal domain (CTD) — 52 repeats of YSPTSPS in humans. That CTD is a phosphorylation-regulated docking platform for capping enzymes, splicing factors, polyadenylation machinery, and chromatin modifiers.

Want to learn more? We recommend the skull spinal column ribs and sternum make up the and how many protons does strontium have for further reading.

Initiation requires general transcription factors: TFIIA, TFIIB, TFIID (with TBP), TFIIE, TFIIF, TFIIH. TFIIH has helicase and kinase activity — it melts DNA and phosphorylates the CTD (Ser5 first, then Ser2) to trigger promoter escape and elongation.

Elongation isn't automatic. Pol II pauses ~20–60 nt downstream (promoter-proximal pausing). Practically speaking, release requires P-TEFb kinase (CDK9/Cyclin T), which phosphorylates Ser2, NELF, and DSIF. This pause is a major regulatory checkpoint — think heat shock genes, immediate-early genes.

Termination couples to 3' end processing. The cleavage/polyadenylation complex cuts the nascent RNA, then an exonuclease (Xrn2) degrades the leftover transcript from the 5' end, chasing Pol II off the template (torpedo model). Practical, not theoretical.

RNA Polymerase III: Small but Mighty

17 subunits (~700 kDa). Transcribes

RNA Polymerase III (Pol III) transcribes the short, abundant non‑coding RNAs that fuel the protein‑synthesis machinery: all nuclear‑encoded tRNA genes, the 5S ribosomal RNA component of the large ribosomal subunit, the U6 small nuclear RNA that forms part of the spliceosome, the 7SL signal‑recognition‑particle RNA, and several other small structural RNAs. With 17 subunits and a mass of roughly 700 kDa, Pol III is only modestly larger than Pol II, yet its architecture retains the conserved catalytic core shared with Pol I and Pol II, reflecting a common evolutionary origin.

Promoter architecture and transcription factors
Pol III promoters are unusual because the key control elements often lie *

…within the transcribed region itself, rather than upstream of the start site. Three classic promoter architectures have been defined:

• Type 1 promoters – found upstream of 5S rRNA genes. They contain an internal A‑box and C‑box that are bound by the transcription factor TFIIIA. TFIIIA then recruits TFIIIB (composed of TBP, Brf1, and Bdp1) and TFIIIC, which together position Pol III at the transcription start site.

• Type 2 promoters – characteristic of tRNA genes and some other small RNAs. These promoters consist of two internal sequence elements, the A‑box and B‑box, located within the coding region. TFIIIC binds directly to these boxes, which in turn recruits TFIIIB; TFIIIA is not required for type 2 promoters.

• Type 3 promoters – drive transcription of U6 snRNA, 7SK RNA, and a few other nuclear RNAs. Unlike type 1 and type 2, the core promoter elements reside upstream of the transcription start site: a proximal sequence element (PSE) and a TATA‑like box. TFIIIC binds the PSE, while TFIIIB (with Brf2 instead of Brf1) recognizes the TATA‑like element to assemble the pre‑initiation complex.

Once assembled, the Pol III pre‑initiation complex melts the DNA, synthesizes a short RNA transcript, and clears the promoter. Termination is signaled by a stretch of four or more thymidines (a poly‑T tract) in the non‑template strand; Pol III pauses and releases the nascent RNA without the need for a dedicated termination factor.

Regulation and cellular impact
Pol III activity is tightly coupled to cellular growth and proliferation. The master regulator MYC directly up‑regulates the expression of TFIIIB subunits and enhances Pol III recruitment to tRNA and 5S rRNA genes. Nutrient‑sensing pathways—particularly mTORC1—phosphorylate Maf1, a global repressor of Pol III; when mTORC1 is active, Maf1 is inactivated, allowing dependable Pol III transcription. Conversely, stress signals (e.g., DNA damage, amino‑acid starvation) activate Maf1, which binds Pol III and blocks its recruitment to promoters, thereby conserving resources.

In cancer, elevated Pol III transcription is a hallmark of aggressive phenotypes. Increased tRNA and 5S rRNA synthesis supports the heightened demand for protein synthesis, while excess U6 snRNA can alter splicing dynamics. On top of that, pol III‑driven transcripts also feed into non‑coding RNA networks that influence chromatin state and genomic stability. Because of this, Pol III inhibitors (such as ML‑60218 or small‑molecule Maf1 activators) are being explored as therapeutic agents to curb tumor growth.

Conclusion
The three eukaryotic RNA polymerases—Pol I, Pol II, and Pol III—share a common catalytic core yet have diverged in subunit composition, promoter recognition, and regulatory mechanisms to meet distinct transcriptional demands. Pol I dedicates its massive apparatus to the prolific synthesis of rRNA, directly linking nucleolar activity to nutrient signaling and cancer‑associated hypertrophy. Pol II, with its versatile CTD and elaborate factor network, governs the expression of protein‑coding genes and most regulatory RNAs, employing promoter‑proximal pausing and tight coupling to 3′‑end processing as key control points. Pol III, though smaller in output size, is indispensable for supplying the translational machinery; its internal promoters and reliance on TFIIIA/B/C enable rapid, high‑volume production of tRNAs, 5S rRNA, and essential small nuclear RNAs, all modulated by growth‑responsive pathways such as mTOR‑Maf1. Together, these polymerases form an integrated transcriptional ecosystem that adjusts RNA output to cellular needs, and their dysregulation contributes fundamentally to diseases ranging from ribosomopathies to malignancy. Understanding the nuances of each polymerase not only illuminates basic biology but also reveals promising targets for therapeutic intervention.